Guard Therapeutics

1.45 SEK

+13.30 %

Less than 1K followers

GUARD

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

+13.30 %
+16.77 %
-9.50 %
-1.50 %
+0.91 %
-90.41 %
-75.45 %
-98.00 %
-99.92 %

Guard Therapeutics is engaged in the development of drugs in the field of oxidative stress. The company focuses primarily on research, development and commercialization of drugs that aim to prevent the onset and complications of acute kidney injury. The drug has been shown in preclinical studies to protect exposed tissue and support regenerative processes. The company is headquartered in Lund.

Read more
Market cap
29.2M SEK
Turnover
57.16K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28.5
2026

General meeting '26

20.8
2026

Interim report Q2'26

12.11
2026

Interim report Q3'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.